These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 22902364)
21. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma. Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090 [TBL] [Abstract][Full Text] [Related]
22. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma. Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877 [TBL] [Abstract][Full Text] [Related]
23. [Significant changes in diagnostic and therapeutic procedures in smoldering multiple myeloma]. Jurczyszyn A; Olszewska-Szopa M; Skotnicki AB Przegl Lek; 2015; 72(11):642-8. PubMed ID: 27012123 [TBL] [Abstract][Full Text] [Related]
33. The road to treating smoldering multiple myeloma. Korde N; Mailankody S; Landgren O Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S59-64. PubMed ID: 25486957 [TBL] [Abstract][Full Text] [Related]
34. Genomic analysis of high-risk smoldering multiple myeloma. López-Corral L; Mateos MV; Corchete LA; Sarasquete ME; de la Rubia J; de Arriba F; Lahuerta JJ; García-Sanz R; San Miguel JF; Gutiérrez NC Haematologica; 2012 Sep; 97(9):1439-43. PubMed ID: 22331267 [TBL] [Abstract][Full Text] [Related]
35. Progress in the Management of Smoldering Multiple Myeloma. Schmidt TM; Callander NS Curr Hematol Malig Rep; 2021 Apr; 16(2):172-182. PubMed ID: 33983517 [TBL] [Abstract][Full Text] [Related]
36. The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective. Caers J; Fernández de Larrea C; Leleu X; Heusschen R; Zojer N; Decaux O; Kastritis E; Minnema M; Jurczyszyn A; Beguin Y; Wäsch R; Palumbo A; Dimopoulos M; Mateos MV; Ludwig H; Engelhardt M Oncologist; 2016 Mar; 21(3):333-42. PubMed ID: 26921288 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation. Gertz MA; Witzig TE; Pineda AA; Greipp PR; Kyle RA; Litzow MR Bone Marrow Transplant; 1997 Feb; 19(4):337-42. PubMed ID: 9051243 [TBL] [Abstract][Full Text] [Related]
38. MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology. Mateos MV; Landgren O Cancer Treat Res; 2016; 169():3-12. PubMed ID: 27696254 [TBL] [Abstract][Full Text] [Related]
39. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma. Lemoli RM; Cavo M; Fortuna A J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709 [TBL] [Abstract][Full Text] [Related]
40. Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy. Sanoja-Flores L; Flores-Montero J; Puig N; Contreras-Sanfeliciano T; Pontes R; Corral-Mateos A; García-Sánchez O; Díez-Campelo M; Pessoa de Magalhães RJ; García-Martín L; Alonso-Alonso JM; García-Mateo A; Aguilar-Franco C; Labrador J; Barez-García A; Maiolino A; Paiva B; San Miguel J; Sobral da Costa E; González M; Mateos MV; Durie B; van Dongen JJM; Orfao A Blood; 2019 Dec; 134(24):2218-2222. PubMed ID: 31697808 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]